Health
UK to start HEAL-COVID trial to reduce mortality,re-admission rate among Covid survivors – BusinessLine
This will be carried out in collaboration with the Liverpool Clinical Trials Centre at the University of Liverpool and Wrexham-based clinical trial technology firm…
The United Kingdom is set to initiate a drug trial called HEAL-COVID in an effort to alleviate the mortality rate and readmission cases in patients who have previously been hospitalised with the novel coronavirus.
According to the report by Clinical Trials Arena, data collated by the UK Office for National Statistics indicated that 29 per cent of Covid-19 hospitalised patients were readmitted within six months. While more than 12 per cent died within the same period.
So, the new trial will help…
-
Noosa News20 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News24 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
Noosa News18 hours agoMissing man, Maroochydore – Queensland Police News
-
General21 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out